Abstract

PurposeHeart failure is among the leading causes for hospitalization in Europe. In this study, we evaluate potential precipitating factors for hospitalization for heart failure and shock.MethodsUsing Swiss claims data (2014–2015), we evaluated the association between hospitalization for heart failure and shock, and prescription of oral potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), and amoxicillin/clavulanic acid. We conducted case-crossover analyses, where exposure was compared for the hazard period and the primary control period (e.g., 1–30 days before hospitalization vs. 31–60 days, respectively). Conditional logistic regression was applied and subsequently adjusted for addressing potential confounding by disease progression. Sensitivity analyses were conducted and stratification for co-medication was performed.ResultsWe identified 2185 patients hospitalized with heart failure or shock. Prescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid was significantly associated with an increased risk for hospitalization for heart failure and shock with crude odds ratios (OR) of 2.04 for potassium (95% CI 1.24–3.36, p = 0.005, 30 days), OR 1.8 for NSAIDs (95% CI 1.39–2.33, p < 0.0001, 30 days), and OR 3.25 for amoxicillin/clavulanic acid (95% CI 2.06–5.14, p < 0.0001, 15 days), respectively. Adjustment attenuated odds ratios, while the significant positive association remained (potassium OR 1.70 (95% CI 1.01–2.86, p = 0.046), NSAIDs OR 1.50 (95% CI 1.14–1.97, p = 0.003), and amoxicillin/clavulanic acid OR 2.26 (95% CI 1.41–3.62, p = 0.001).ConclusionPrescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid is associated with increased risk for hospitalization. Underlying conditions such as pain, electrolyte imbalances, and infections are likely contributing risk factors. Physicians may use this knowledge to better identify patients at risk and adapt patient management.

Highlights

  • Heart failure (HF) is among the leading causes for hospitalization in Europe, especially in the elderly [1], with an estimated prevalence of 1–2% in the western world [2]

  • Prescription of potassium supplements and non-steroidal antiinflammatory drugs was significantly associated with an increased probability for hospitalization for heart failure and shock with odds ratios of 2.04 for potassium and 1.8 for non-steroidal anti-inflammatory drugs (NSAIDs) in all 2185 patients

  • Odds ratios of 2.64 for potassium, 2.07 for NSAIDs, and 3.37 for amoxicillin/clavulanic acid

Read more

Summary

Introduction

Heart failure (HF) is among the leading causes for hospitalization in Europe, especially in the elderly [1], with an estimated prevalence of 1–2% in the western world [2]. Gaining insight into the development of patients’ healthcare-seeking behavior towards hospitalization and subsequent identification of risk factors for HF decompensation. The American Heart Association released a list of medications that could exacerbate HF [4], covering drugs from thirteen distinct therapeutic classes. Prescriptions for these medications in HF patients are still common. A study evaluating National Health and Nutrition Examination Survey data from the USA found a prevalence of 48% of heart failure exacerbating medication use [5]

Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call